Mangoceuticals (MGRX) Cash & Equivalents (2023 - 2025)
Historic Cash & Equivalents for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $481281.0.
- Mangoceuticals' Cash & Equivalents rose 55115.41% to $481281.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $481281.0, marking a year-over-year increase of 55115.41%. This contributed to the annual value of $58653.0 for FY2024, which is 9206.33% down from last year.
- According to the latest figures from Q3 2025, Mangoceuticals' Cash & Equivalents is $481281.0, which was up 55115.41% from $101019.0 recorded in Q2 2025.
- Mangoceuticals' 5-year Cash & Equivalents high stood at $2.9 million for Q2 2023, and its period low was $15305.0 during Q1 2024.
- Over the past 3 years, Mangoceuticals' median Cash & Equivalents value was $291150.0 (recorded in 2025), while the average stood at $622015.7.
- In the last 5 years, Mangoceuticals' Cash & Equivalents crashed by 9402.37% in 2024 and then surged by 55115.41% in 2025.
- Over the past 3 years, Mangoceuticals' Cash & Equivalents (Quarter) stood at $739006.0 in 2023, then plummeted by 92.06% to $58653.0 in 2024, then skyrocketed by 720.56% to $481281.0 in 2025.
- Its Cash & Equivalents stands at $481281.0 for Q3 2025, versus $101019.0 for Q2 2025 and $76496.0 for Q1 2025.